Reviewer Thank You List.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 4, p. 299, doi. 10.1177/1758834017704335
- Publication type:
- Article
Works matching IS 17588340 AND DT 2017 AND VI 9 AND IP 4
Results: 6
1
2
Clinical effectiveness and toxicity of second-line irinotecan in advanced gastric and gastroesophageal junction adenocarcinoma: a single-center observational study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 4, p. 223, doi. 10.1177/1758834016689029
- By:
- Publication type:
- Article
3
Combination of metformin and curcumin targets breast cancer in mice by angiogenesis inhibition, immune system modulation and induction of p53 independent apoptosis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 4, p. 235, doi. 10.1177/1758834016687482
- By:
- Publication type:
- Article
4
Moving beyond vascular endothelial growth factor-targeted therapy in renal cell cancer: latest evidence and therapeutic implications.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 4, p. 287, doi. 10.1177/1758834016687261
- By:
- Publication type:
- Article
5
A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 4, p. 269, doi. 10.1177/1758834016687260
- By:
- Publication type:
- Article
6
PARP inhibitors in ovarian cancer: evidence, experience and clinical potential.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 4, p. 253, doi. 10.1177/1758834016687254
- By:
- Publication type:
- Article